Metformin attenuates cardiac remodeling in mice through the Nrf2/Keap1 signaling pathway
Obesity results in a variety of metabolic alterations that may contribute to abnormalities in cardiac structure and function. Although metformin (Met) has been previously reported to exhibit beneficial effects against cardiomyopathy associated obesity, the mechanism underlying this observation remai...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388283/ https://www.ncbi.nlm.nih.gov/pubmed/32742327 http://dx.doi.org/10.3892/etm.2020.8764 |